These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28940316)

  • 41. Cost-effectiveness analysis of a pragmatic randomized trial evaluating surgical reconstruction versus rehabilitation in patients with long-standing anterior cruciate ligament injury.
    Leal J; Mirza B; Davies L; Fletcher H; Stokes J; Cook JA; Price A; Beard DJ
    Bone Joint J; 2024 Jan; 106-B(1):38-45. PubMed ID: 38160685
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cost-effectiveness analysis of sequential biologic therapy with ixekizumab versus secukinumab as first-line treatment of moderate-to-severe psoriasis in the UK.
    Johansson EC; Hartz S; Kiri SH; Kumar G; Svedbom A
    J Med Econ; 2018 Aug; 21(8):810-820. PubMed ID: 29873270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Economic evaluation of an extended nutritional intervention in older Australian hospitalized patients: a randomized controlled trial.
    Sharma Y; Thompson C; Miller M; Shahi R; Hakendorf P; Horwood C; Kaambwa B
    BMC Geriatr; 2018 Feb; 18(1):41. PubMed ID: 29402228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cost-Effectiveness and Net Monetary Benefit of Olaparib Maintenance Therapy Versus No Maintenance Therapy After First-line Platinum-based Chemotherapy in Newly Diagnosed Advanced BRCA1/2-mutated Ovarian Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Colombo N; Costa F
    Clin Ther; 2020 Jul; 42(7):1192-1209.e12. PubMed ID: 32591103
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness and cost-utility of add-on, low-dose prednisolone in patients with rheumatoid arthritis aged 65+: The pragmatic, multicenter, placebo-controlled GLORIA trial.
    Hartman L; El Alili M; Cutolo M; Opris D; Da Silva J; Szekanecz Z; Buttgereit F; Masaryk P; Bos R; Kok MR; Paolino S; Coupé V; Lems WF; Boers M;
    Semin Arthritis Rheum; 2022 Dec; 57():152109. PubMed ID: 36335684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of Atezolizumab Plus Bevacizumab vs Sorafenib as First-Line Treatment of Unresectable Hepatocellular Carcinoma.
    Su D; Wu B; Shi L
    JAMA Netw Open; 2021 Feb; 4(2):e210037. PubMed ID: 33625508
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study. The REFLUX trial.
    Grant A; Wileman S; Ramsay C; Bojke L; Epstein D; Sculpher M; Macran S; Kilonzo M; Vale L; Francis J; Mowat A; Krukowski Z; Heading R; Thursz M; Russell I; Campbell M;
    Health Technol Assess; 2008 Sep; 12(31):1-181, iii-iv. PubMed ID: 18796263
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cost-effectiveness and Net Monetary Benefit of Durvalumab Consolidation Therapy Versus No Consolidation Therapy After Chemoradiotherapy in Stage III Non-small Cell Lung Cancer in the Italian National Health Service.
    Armeni P; Borsoi L; Fornaro G; Jommi C; Grossi F; Costa F
    Clin Ther; 2020 May; 42(5):830-847. PubMed ID: 32354495
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstruction.
    Noble SM; Ahern AM; Worthington J; Hashim H; Taylor H; Young GJ; Brookes S; Abrams P; Johnson L; Khan R; Page T; Swami KS; Lane JA
    BJU Int; 2020 Nov; 126(5):595-603. PubMed ID: 32558178
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A systematic review of treatments for bullous pemphigoid.
    Khumalo NP; Murrell DF; Wojnarowska F; Kirtschig G
    Arch Dermatol; 2002 Mar; 138(3):385-9. PubMed ID: 11902990
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cost-Effectiveness of a Multifaceted Podiatry Intervention for the Prevention of Falls in Older People: The REducing Falls with Orthoses and a Multifaceted Podiatry Intervention Trial Findings.
    Corbacho B; Cockayne S; Fairhurst C; Hewitt CE; Hicks K; Kenan AM; Lamb SE; MacIntosh C; Menz HB; Redmond AC; Rodgers S; Scantlebury A; Watson J; Torgerson DJ;
    Gerontology; 2018; 64(5):503-512. PubMed ID: 29945150
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical effectiveness and cost-effectiveness of collaborative care for depression in UK primary care (CADET): a cluster randomised controlled trial.
    Richards DA; Bower P; Chew-Graham C; Gask L; Lovell K; Cape J; Pilling S; Araya R; Kessler D; Barkham M; Bland JM; Gilbody S; Green C; Lewis G; Manning C; Kontopantelis E; Hill JJ; Hughes-Morley A; Russell A
    Health Technol Assess; 2016 Feb; 20(14):1-192. PubMed ID: 26910256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-utility of cognitive behavioral therapy versus U.S. Food and Drug Administration recommended drugs and usual care in the treatment of patients with fibromyalgia: an economic evaluation alongside a 6-month randomized controlled trial.
    Luciano JV; D'Amico F; Cerdà-Lafont M; Peñarrubia-María MT; Knapp M; Cuesta-Vargas AI; Serrano-Blanco A; García-Campayo J
    Arthritis Res Ther; 2014 Oct; 16(5):451. PubMed ID: 25270426
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-Effectiveness of Sertraline in Primary Care According to Initial Severity and Duration of Depressive Symptoms: Findings from the PANDA RCT.
    Hollingworth W; Fawsitt CG; Dixon P; Duffy L; Araya R; Peters TJ; Thom H; Welton NJ; Wiles N; Lewis G;
    Pharmacoecon Open; 2020 Sep; 4(3):427-438. PubMed ID: 31777008
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cost-effectiveness of hydroxychloroquine
    Ronaldson SJ; Keding A; Tharmanathan P; Arundel C; Kingsbury SR; Conaghan PG; Torgerson DJ
    F1000Res; 2021; 10():821. PubMed ID: 34950454
    [No Abstract]   [Full Text] [Related]  

  • 58. Budesonide with multi-matrix technology as second-line treatment for ulcerative colitis: evaluation of long-term cost-effectiveness in the Netherlands.
    Gherardi A; Roze S; Kuijvenhoven J; Ghatnekar O; Yip Sonderegger YL
    J Med Econ; 2018 Sep; 21(9):869-877. PubMed ID: 29857775
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A multicentred randomised controlled trial of a primary care-based cognitive behavioural programme for low back pain. The Back Skills Training (BeST) trial.
    Lamb SE; Lall R; Hansen Z; Castelnuovo E; Withers EJ; Nichols V; Griffiths F; Potter R; Szczepura A; Underwood M;
    Health Technol Assess; 2010 Aug; 14(41):1-253, iii-iv. PubMed ID: 20807469
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Total hip replacement and surface replacement for the treatment of pain and disability resulting from end-stage arthritis of the hip (review of technology appraisal guidance 2 and 44): systematic review and economic evaluation.
    Clarke A; Pulikottil-Jacob R; Grove A; Freeman K; Mistry H; Tsertsvadze A; Connock M; Court R; Kandala NB; Costa M; Suri G; Metcalfe D; Crowther M; Morrow S; Johnson S; Sutcliffe P
    Health Technol Assess; 2015 Jan; 19(10):1-668, vii-viii. PubMed ID: 25634033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.